Researchers at Griffith University’s Institute for Glycomics have been able to induce malaria immunity in animals and are now poised to advance first-stage human trials.
The new study introduced a holistic approach by working with an immune response to the whole malaria parasite, compared to previous studies that only focused on individual antigens on the parasite or the infected red blood cells.
“There are currently 247 million cases of malaria across 109 different countries,” Professor Michael Good said. “Of the million sufferers who die each year, 85% are young children who are simply not strong enough to fight off the killer parasite. If this vaccine works, the world will be a very different place.”
Read more at Griffith University